ASH

December 10, 2019

61st American Society of Hematology (ASH) Annual Meeting, December 7-10, 2019, Orlando, FL, USA

Year

2019

Assets in this page

Download assets

  • pdf file

    "SEL120 – a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome – Data from Preclinical Studies and Introduction to a Phase Ib Clinical Trial"

    Download
  • pdf file

    "CDK8 Inhibitors Induce Transcriptional Reprogramming of AML Cells Associated with Differentiation"

    Download